PTGFRN Protein, Cynomolgus, Recombinant (His)
Ref. TM-TMPY-03876
| 100µg | 647.00 € |
Product Information
- prostaglandin F2 receptor inhibitor
EWI-F, also known as PTGFRN, is inversely related to the loss of CD9. Its expression correlates with the metastatic status of hLT. EWI-F inhibits the binding of prostaglandin F2-alpha (PGF2-alpha) to its specific FP receptor, by decreasing the receptor number rather than the affinity constant. EWI-F expression positively correlates with the metastatic status of hLT, and that the upregulation of EWI-F expression could be one of the mechanisms underlying the loss of CD9 in solid tumours.
Chemical properties
Technical inquiry about: TM-TMPY-03876 PTGFRN Protein, Cynomolgus, Recombinant (His)
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
